Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Echosens · with Syneos Health · NCT07222813
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 149
- US sites recruiting
- 3
- Study start
- April 23, 2026
- Record last updated
- September 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a pivotal, global, prospective, cross-sectional, multicentric clinical investigation designed to explore a non-invasive, reliable alternative to invasive, catheter-based hemodynamic assessments, which are associated with procedural risks and limited applicability in certain participant populations.
Being studied: FibroScan; Right-sided Heart Catheterization; Transthoracic echocardiography; Blood Sample Analysis
Conditions: Heart Failure; Heart Failure - NYHA II - IV
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Have read, understood, and signed the informed consent form (ICF)
- Be ≥18 years of age at the time of screening
- Have suspected or diagnosed acute or chronic HF and be scheduled to undergo right-sided cardiac catheterization
Exclusion Criteria
- Inability to consent
- Chronic liver disease (self-reported alcohol use >14 drinks/week in females and >21 drinks/week in males), positive hepatitis C virus serology, positive hepatitis B surface antigen, autoimmune hepatitis, hemochromatosis, or cholestatic disease)
- BMI >40 kg/m2
- Fontan-type circulation
- Ascites
- Heart transplantation
- Pregnancy, breastfeeding, or intent to become pregnant during the study
- Intent to donate/bank or retrieve eggs (ova, oocytes) or donate sperm during the study
Recruiting US locations
University of Minnesota
Minneota, MN 55455
Site contact: Tamas Alexy, MD · 612-626-1240 · alexy001@umn.edu
Medical University of South Carolina
Charleston, SC 29425
Site contact: Michele Esposito, MD · 843-792-1105 · espositm@musc.edu
University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location
Dallas, TX 75390
Site contact: Ambarish Pandey, MD, MSCS, FAHA · 214-645-2101 · ambarish.pandey@utsouthwestern.edu
Study contacts (from the official record)
- CAROLE MEILLEROUX, PharmD · +33622649277 · carole.meilleroux@echosens.com
Similar studies in Minnesota
All heart & blood pressure studies in Minnesota →- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Rochester, MN + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
- Location
- Rochester, MN + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Minneapolis, MN + 64 other US sites
- Eligibility basics
- Ages 18+